· Published by Health Canada · Official notice
This is duplicated text of a letter from Baxter Corporation Canada. Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
May 15, 2012
Dear Director of Biomedical Engineering,
Please distribute to all relevant Departments, and other involved professional staff and post this Notice in your institution.
Subject: IMPORTANT PRODUCT INFORMATION - Baxter Colleague Single Channel and Triple Channel Volumetric Infusion Pumps; Models Monochrome, CX and CXE (Product Codes 2M8153, 2M8163, 2M8153R, 2M8163R, 2M8153K, 2M8153KL, 2M8151, 2M8161, 2M8151R, 2M8161R, 2M8151K, 2M8151KL, 2M9163, 2M9161, DNM8153, DNM8153R, DNM8151, DNM8151R, DNM9163, DNM9161)
Baxter Corporation, in collaboration with Health Canada, is providing this letter to make you aware of potential issues that may be observed with COLLEAGUE P1.5 Single Channel and Triple Channel Volumetric Infusion Pumps. These potential issues are summarized below.
The above referenced Baxter Urgent Device Correction Notice, 2008FCA18, was previously posted on Health Canada MedEffect Web site in 2009.
There are no additional actions that need to be taken outside of the information communicated above. Please complete the attached customer reply form and return it to Baxter by fax or scanned e-mail. If you distribute COLLEAGUE Infusion Pumps to other facilities/locations, please disseminate this communication appropriately.
Thank you for your cooperation. We apologize for any inconvenience this may have caused. If you have any questions concerning this communication, or would like copies of the above referenced communications, please do not hesitate to contact your Baxter sales representative.
Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-marketing adverse incidents are generally presumed to underestimate the risks associated with health product treatments. Any serious or unexpected adverse incidents involving Colleague pumps should be reported to Baxter Corporation Canada or Health Canada at the following addresses:
Baxter Corporation Canada
4 Robert Speck Parkway
Mississauga, ON
L4Z 3Y4
To correct your mailing address or fax number, also contact Baxter Corporation Canada.
Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675
The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.
For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc.public@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738
Yours Sincerely,
original signed by
Phil Lynch
Director, Quality, Baxter Corporation Canada
IMPORTANT PRODUCT INFORMATION
COLLEAGUE INFUSION PUMPS P1.5
Important Product Information dated May 15, 2012
Please complete and return this form to the FAX number listed below or email to fca_canada@baxter.com as confirmation that you have received this notification.
Fax# 1-855-767-4572
A fax cover sheet is not required.
Your Prompt Reply will Prevent a Repeat Notice
PLEASE ENSURE THE INFORMATION BELOW IS COMPLETE. INCOMPLETE FORMS CANNOT BE PROCESSED.
Facility Name and Address:
If response includes other facilities, please list those facilities:
We understand the contents of the letter, have performed the actions as outlined in the letter as needed, and have disseminated this information to our staff and to other services or facilities, as applicable.
Reply Completed By: (Please print name)
Title: (Please print)
Telephone Number (include Area Code):
Signature/Date: REQUIRED FIELD